Using genetic testing to improve treatment for hypertension and depression in diverse populations.
GeNYC: Genomic Implementation Research in the Diverse Settings and Populations of New York City
This study is looking at how genetic testing can help doctors choose the best treatments for conditions like high blood pressure, depression, and pain, especially for people in New York City, so that everyone can benefit from personalized care.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11074366 on NIH RePORTER |
What this research studies
This research investigates how genetic testing can guide treatment decisions for conditions like hypertension, depression, and pain in diverse populations, particularly in New York City. It involves two clinical trials that will assess the effectiveness of genotype-guided therapies, aiming to ensure that genomic medicine is accessible and relevant to various demographic groups. Patients will be monitored to evaluate how these personalized approaches impact their health outcomes over time.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults of African ancestry who are dealing with hypertension, depression, or chronic pain.
Not a fit: Patients who do not have hypertension, depression, or chronic pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with hypertension and depression.
How similar studies have performed: Previous research has shown promising results in using genetic testing to tailor treatments for various conditions, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Horowitz, Carol R — Icahn School of Medicine at Mount Sinai
- Study coordinator: Horowitz, Carol R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.